Vaccine prevention of meningococcal disease in Africa: Major advances, remaining challenges
Authors:
- 16 January 2018
- journal article
- review article
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 14 (5) , 1107-1115
Abstract
Africa historically has had the highest incidence of meningococcal disease with high endemic rates and periodic epidemics. The meningitis belt, a region of sub-Saharan Africa extending from Senegal to Ethiopia, has experienced large, devastating epidemics. However, dramatic shifts in the epidemiology of meningococcal disease have occurred recently. For instance, meningococcal capsular group A (NmA) epidemics in the meningitis belt have essentially been eliminated by use of conjugate vaccine. However, NmW epidemics have emerged and spread across the continent since 2000; NmX epidemics have occurred sporadically, and NmC recently emerged in Nigeria and Niger. Outside the meningitis belt, NmB predominates in North Africa, while NmW followed by NmB predominate in South Africa. Improved surveillance is necessary to address the challenges of this changing epidemiologic picture. A low-cost, multivalent conjugate vaccine covering NmA and the emergent and prevalent meningococcal capsular groups C, W, and X in the meningitis belt is a pressing need.Keywords
This publication has 90 references indexed in Scilit:
- Meningococcal disease in the Middle East and Africa: Findings and updates from the Global Meningococcal InitiativeJournal of Infection, 2017
- Towards understanding the epidemiology of Neisseria meningitidis in the African meningitis belt: a multi-disciplinary overviewInternational Journal of Infectious Diseases, 2017
- Resurgence of Neisseria meningitidis serogroup W ST-11 (cc11) in Madagascar, 2015–2016International Journal of Infectious Diseases, 2016
- Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineageJournal of Infection, 2015
- Genomic Epidemiology of Hypervirulent Serogroup W, ST-11 Neisseria meningitidisEBioMedicine, 2015
- Meningococcal Vaccines: Current Issues and Future StrategiesDrugs, 2013
- Meningococcal disease in the Middle East and North Africa: an important public health consideration that requires further attentionInternational Journal of Infectious Diseases, 2012
- Characterization of Neisseria meningitidis isolates from Egypt using multilocus sequence typingTransactions of the Royal Society of Tropical Medicine and Hygiene, 2012
- A hypothetical explanatory model for meningococcal meningitis in the African meningitis beltInternational Journal of Infectious Diseases, 2010
- The first large epidemic of meningococcal disease caused by serogroup W135, Burkina Faso, 2002Vaccine, 2007